Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta-Delayed Neutron Emission of N=84 ^{132}Cd.

Physical review letters·2026
Same author

Increasing Octupole Collectivity across the Z=64 Isotopic Chain: B(E3) Values in ^{150}Gd.

Physical review letters·2025
Same author

Intrinsic hydrophobicity of IDP-based biomolecular condensates drives their partial drying on membrane surfaces.

The Journal of chemical physics·2025
Same author

Deformation and Collectivity in Doubly Magic ^{208}Pb.

Physical review letters·2025
Same author

The human HELQ helicase and XRN2 exoribonuclease cooperate in R-loop resolution.

Open biology·2025
Same author

Reproductive resilience: pathways to gametogenic success in Montipora capitata after bleaching.

Scientific reports·2024

Related Experiment Video

Updated: Jul 6, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

Towards new copper based radiopharmaceuticals.

P Barnard1, S Bayly, H Betts

  • 1Siemens Oxford Molecular Imaging Laboratory, Chemistry Research Laboratory, University of Oxford, Oxford, UK.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of
|March 21, 2008
PubMed
Summary

Researchers explored copper and zinc complexes for hypoxia selectivity. Modified complexes and new macrocyclic ligands were synthesized, with some showing resistance to copper loss in vivo.

More Related Videos

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group
07:23

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group

Published on: October 10, 2016

Related Experiment Videos

Last Updated: Jul 6, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group
07:23

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group

Published on: October 10, 2016

Area of Science:

  • Coordination Chemistry
  • Medicinal Inorganic Chemistry

Background:

  • Bis(thiosemicarbazonato) complexes of zinc and copper are investigated for their chemical, spectroscopic, and redox properties.
  • The hypoxia selectivity of copper(II) complexes is a key area of focus.

Purpose of the Study:

  • To review ongoing research on the properties of bis(thiosemicarbazonato) zinc and copper complexes.
  • To explore synthetic strategies for modified complexes and evaluate their in vitro and in vivo characteristics.
  • To synthesize novel bifunctional macrocyclic ligands and their copper(II) derivatives.

Main Methods:

  • Chemical, spectroscopic, and redox property analysis of zinc and copper complexes.
  • Synthesis of modified complexes with functional substituents.
  • In vitro and in vivo evaluation of complex derivatives.
  • Synthesis of bifunctional macrocyclic ligands.

Main Results:

  • Detailed characterization of chemical, spectroscopic, and redox properties.
  • Demonstration of hypoxia selectivity in copper(II) complexes.
  • Evaluation of in vitro and in vivo behavior of modified complexes.
  • Successful synthesis of novel macrocyclic ligands and their copper(II) derivatives.
  • Identification of copper(II) derivatives resistant to reductive loss in vivo due to non-reducibility.

Conclusions:

  • Modified bis(thiosemicarbazonato) complexes offer potential for targeted applications.
  • Novel macrocyclic ligands provide a route to copper complexes with enhanced stability in vivo.
  • The redox properties of these complexes are crucial for their biological activity and stability.